Idun And Abbott Extend Partnership Agreement

, Inc. has extended their worldwide research and development agreement with focusing on the discovery and development of products to treat people with cancer.

Under this agreement, Abbott and Idun will continue their collaboration to discover drugs that regulate the activity of specific proteins involved in the cell pathways leading to programmed cell death, or apoptosis.

This strategic initiative combines proprietary technologies from both Abbott and Idun in a major discovery effort to identify small molecule drugs that kill tumour cells by specifically targeting the apoptosis pathway.

Under the original collaboration, which began in 1998, Idun developed primary molecular assays against targets in the core of the apoptosis pathway.

Abbott uses these assays for high-throughput screening of compound libraries and for compound design using Abbott’s proprietary Structure Activity Relationships by Nuclear Magnetic Resonance (SAR by NMR) technology.

Secondary screening is carried out by Idun using its battery of proprietary biological apoptosis assays.

“During the past three years we have made significant progress in the discovery of innovative treatments for cancer through our partnership with Abbott Laboratories,” says Dr. Steven J. Mento, President and CEO, Idun Pharmaceuticals.

“The collaborative program between Abbott and Idun for cancer research has been successful to date and we are pleased to be able to extend our collaboration with Idun,” says Steve Fesik, Ph.D., Divisional Vice President, Cancer Research at Abbott Laboratories.

Idun Pharmaceuticals, Inc. creates innovative human therapeutics with a primary focus on controlling apoptosis, or programmed cell death.

Idun believes that controlling the cell death process will have utility in treating cancer, neurodegenerative diseases, ischemic disorders and cardiovascular disease.

Shopping Dragon Pharma LLC Ready for Use

Enantat 250 - Bulk Price

Administration: Injection
Basic Substance: Testosterone Enanthate
Manufacturer: Dragon Pharma LLC
Package: 10 x 10 mL vial (250 mg/mL)
Price: 10 x $36.00

Primobolan 200

Injectable Anabolic Steroid
Basal Component: Methenolone Enanthate
Producer: Dragon Pharmaceuticals
Amount: 1 X 10 mL vial (200 mg/mL)

Dianabol 20 - Bulk Price

Administration: Oral
Base Component: Methandrostenolone
Branded by: Dragon Pharma
Amount: 10 x 100 tabs (20 mg/pill)
Price: 10 x $39.00

Nolvadex - Bulk Price

Administration: Oral
Basic Ingredient: Tamoxifen Citrate
Manufacturer: Dragon Pharmaceuticals
Unit: 10 x 100 tablets (20 mg/pill)
Price: 10 x $40.00

TriTren 150 - Cheap Price

Administration: Injection
Active Substance: Tri Trenbolone
Producer: Dragon Pharmaceutical
Amount: 20 x 10 mL vial (150 mg/mL)
Price: 20 x $65.00

Propionat 100 - Bulk Price

Administration: Injection
Principal Constituent: Testosterone Propionate
Manufacturer: Dragon Pharma Labs
Pack: 10 x 10 mL vial (100 mg/mL)
Price: 10 x $30.00

Trenbolone 50

Injectable Anabolic Steroid
Main Chemical Name: Trenbolone Suspension
Made by: Dragon Pharma
Amount: 1 X 10 mL vial (50 mg/mL)

Dianabol 20 - Cheap Price

Administration: Oral
Basal Constituent: Methandrostenolone
Made by: Dragon Pharma
Package: 20 x 100 pills (20 mg/tablet)
Price: 20 x $32.00

Clenbuterol

Active Constituent: Clenbuterol Hydrochloride
Producer: Dragon Pharma
Package: 100 tablets (40 mcg/pill)

Primobolan 100 [10 Vials]

Injectable Steroid for Muscle Growth
Main Constituent: Methenolone Enanthate
Produced by: Dragon Pharma Labs
10 Vials [10 mL per Vial (100 mg/ml)]
Price: 10 x $75.00 = $750.00 in Total

Cut Mix 150

Injectable Steroid for Muscle Growth
Mix of: Testosterone Propionate,
Drostanolone Propionate, Trenbolone Acetate
Made by: Dragon Pharma LLC
10 mL Sterile Multi-dose Vial (150 mg/mL)

Oxymetholon

Oral Steroid for Muscle Growth
Primary Ingredient: Oxymetholone
Producer: Dragon Pharma Labs
100 tabs (50 mg/tab)